{"entity":{"type":"insider","cik":"0001410289","url":"/insider/0001410289","json_url":"/insider/0001410289.json","name":"Szela Mary T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":76,"n_filings":22,"first":"2007-09-13","last":"2026-07-06","span_basis":"filed_date"},"name_variants":[{"name":"Szela Mary T","source":"filing","n_filings":22,"first_seen":"2007-09-13","last_seen":"2026-07-06"}],"transactions":[{"id":6078072,"accession":"0001672688-26-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001672688-26-000124","line_url":"/filing/0001672688-26-000124#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"Absci Corp","issuer_ticker":"ABSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12900.0,"shares_display":"12,900","price_per_share":11.54,"price_display":"11.54","price_state":"stated","total_value":148866.0,"total_display":"148,866.00","total_whole":"148,866","shares_owned_after":21300.0,"shares_owned_after_display":"21,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-06","scope":"insider"},{"id":6173525,"accession":"0001628280-26-035994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-035994","line_url":"/filing/0001628280-26-035994#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39682.0,"shares_display":"39,682","price_per_share":2.59,"price_display":"2.59","price_state":"stated","total_value":102776.38,"total_display":"102,776.38","total_whole":"102,776","shares_owned_after":1065215.0,"shares_owned_after_display":"1,065,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider"},{"id":5917759,"accession":"0001628280-26-020186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-020186","line_url":"/filing/0001628280-26-020186#line-2","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15944.0,"shares_display":"15,944","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":61384.4,"total_display":"61,384.40","total_whole":"61,384","shares_owned_after":752987.0,"shares_owned_after_display":"752,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-20","scope":"insider"},{"id":5917757,"accession":"0001628280-26-020186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-020186","line_url":"/filing/0001628280-26-020186#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4358.0,"shares_display":"4,358","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":17998.54,"total_display":"17,998.54","total_whole":"17,999","shares_owned_after":768931.0,"shares_owned_after_display":"768,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-20","scope":"insider"},{"id":5814225,"accession":"0001628280-26-010603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-010603","line_url":"/filing/0001628280-26-010603#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30487.0,"shares_display":"30,487","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":124996.7,"total_display":"124,996.70","total_whole":"124,997","shares_owned_after":773289.0,"shares_owned_after_display":"773,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-23","scope":"insider"},{"id":4356951,"accession":"0001415889-25-002536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002536","line_url":"/filing/0001415889-25-002536#line-2","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5010.0,"shares_display":"5,010","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":26452.8,"total_display":"26,452.80","total_whole":"26,453","shares_owned_after":444259.0,"shares_owned_after_display":"444,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":4356947,"accession":"0001415889-25-002536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002536","line_url":"/filing/0001415889-25-002536#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5030.0,"shares_display":"5,030","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":25300.9,"total_display":"25,300.90","total_whole":"25,301","shares_owned_after":439249.0,"shares_owned_after_display":"439,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-31","scope":"insider"},{"id":4918957,"accession":"0001415889-25-002292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-002292","line_url":"/filing/0001415889-25-002292#line-3","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4716.0,"shares_display":"4,716","price_per_share":5.12,"price_display":"5.12","price_state":"stated","total_value":24145.92,"total_display":"24,145.92","total_whole":"24,146","shares_owned_after":434219.0,"shares_owned_after_display":"434,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":4918955,"accession":"0001415889-25-002292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002292","line_url":"/filing/0001415889-25-002292#line-2","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4826.0,"shares_display":"4,826","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":26156.92,"total_display":"26,156.92","total_whole":"26,157","shares_owned_after":429503.0,"shares_owned_after_display":"429,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":2190687,"accession":"0001415889-24-023390","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-023390","line_url":"/filing/0001415889-24-023390","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7295.0,"shares_display":"7,295","price_per_share":4.969821795750514,"price_display":"4.97","price_state":"stated","total_value":36254.85,"total_display":"36,254.85","total_whole":"36,255","shares_owned_after":384677.0,"shares_owned_after_display":"384,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-13","scope":"insider","n_lines":2},{"id":2190680,"accession":"0001415889-24-023390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023390","line_url":"/filing/0001415889-24-023390#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7520.0,"shares_display":"7,520","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":39104.0,"total_display":"39,104.00","total_whole":"39,104","shares_owned_after":377382.0,"shares_owned_after_display":"377,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-13","scope":"insider"},{"id":2392348,"accession":"0001415889-24-023320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023320","line_url":"/filing/0001415889-24-023320#line-1","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director, Officer (CEO AND PRESIDENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO AND PRESIDENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.97,"price_display":"4.97","price_state":"stated","total_value":24850.0,"total_display":"24,850.00","total_whole":"24,850","shares_owned_after":369862.0,"shares_owned_after_display":"369,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2921485,"accession":"0001567619-20-012534","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-20-012534","line_url":"/filing/0001567619-20-012534#line-4","is_derivative":false,"issuer_cik":"0001410289","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001410289","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54997.0,"shares_display":"54,997","price_per_share":17.5784,"price_display":"17.58","price_state":"stated","total_value":966759.2648,"total_display":"966,759.26","total_whole":"966,759","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":9091547,"accession":"0001179110-11-016829","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001179110-11-016829","line_url":"/filing/0001179110-11-016829","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53201.0,"shares_display":"53,201","price_per_share":54.392294411759174,"price_display":"54.39","price_state":"stated","total_value":2893724.455,"total_display":"2,893,724.46","total_whole":"2,893,724","shares_owned_after":155793.0,"shares_owned_after_display":"155,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-14","filed_date":"2011-12-16","scope":"insider","n_lines":26},{"id":8984734,"accession":"0001179110-11-005770","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-005770","line_url":"/filing/0001179110-11-005770","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15960.0,"shares_display":"15,960","price_per_share":49.2515194235589,"price_display":"49.25","price_state":"stated","total_value":786054.25,"total_display":"786,054.25","total_whole":"786,054","shares_owned_after":121767.0,"shares_owned_after_display":"121,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-04-01","scope":"insider","n_lines":2},{"id":9043113,"accession":"0001179110-11-003924","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-11-003924","line_url":"/filing/0001179110-11-003924","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17267.0,"shares_display":"17,267","price_per_share":48.11851856141773,"price_display":"48.12","price_state":"stated","total_value":830862.46,"total_display":"830,862.46","total_whole":"830,862","shares_owned_after":122342.0,"shares_owned_after_display":"122,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-02","scope":"insider","n_lines":6},{"id":9043107,"accession":"0001179110-11-003924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-003924","line_url":"/filing/0001179110-11-003924#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1988.0,"shares_display":"1,988","price_per_share":48.303,"price_display":"48.30","price_state":"stated","total_value":96026.364,"total_display":"96,026.36","total_whole":"96,026","shares_owned_after":136609.0,"shares_owned_after_display":"136,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-02","scope":"insider"},{"id":7172895,"accession":"0001179110-10-004227","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-10-004227","line_url":"/filing/0001179110-10-004227#line-14","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001410289","owner_name":"Szela Mary T","owner_display_name":"Szela Mary T","owner_url":"/insider/0001410289","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":54.52,"price_display":"54.52","price_state":"stated","total_value":245340.0,"total_display":"245,340.00","total_whole":"245,340","shares_owned_after":128357.0,"shares_owned_after_display":"128,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-02","scope":"insider"}],"collapsed":true,"next_cursor":"2010-03-01|7172895","ledger_fault":false,"count":{"value":76,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":65,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":76},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672688","name":"Absci Corp","url":"/issuer/0001672688","role":"Director","n_filings":1,"first_seen":"2026-07-06","last_seen":"2026-07-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001826667","name":"TriSalus Life Sciences, Inc.","url":"/issuer/0001826667","role":"Director, Officer (CEO and President)","n_filings":7,"first_seen":"2024-09-12","last_seen":"2026-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001512762","name":"Coherus BioSciences, Inc.","url":"/issuer/0001512762","role":"Director","n_filings":1,"first_seen":"2020-06-24","last_seen":"2020-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (Senior Vice President)","n_filings":13,"first_seen":"2007-09-13","last_seen":"2011-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410289","retrieved_at":"2026-08-23T17:06:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}